Enrofloxacin/BSA
Applications
| Overview | |
| Catalog # | bs-0695pb-1mg |
| Product Name | Enrofloxacin/BSA |
| Applications | Others |
| Specifications | |
| Conjugation | Unconjugated |
| Source | small molecule-conjugated carrier protein |
| Storage Buffer | 0.01M PBS(pH7.4) |
| Storage Condition | Store at -70°C or -20°C. Avoid repeated freeze/thaw cycles. |
| Target | |
| Background | It is a bactericidal agent. The bactericidal activity of enrofloxacin is concentration-dependent, with susceptible bacteria cell death occurring within 20–30 minutes of exposure. Enrofloxacin has demonstrated a significant post-antibiotic effect for both Gram-negative and Gram-positive bacteria and is active in both stationary and growth phases of bacterial replication. Enrofloxacin is partially deethylated by CYP450 into the active metabolite ciprofloxacin, which is also a fluoroquinolone antibiotic, used preferentially in humans. |